Hung IFN et al. |
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial. |
2017 |
Chest |
pmid:27884765
|
Peng X et al. |
Gastric Juice-Based Real-Time PCR for Tailored Treatment: A Practical Approach. |
2017 |
Int J Med Sci |
pmid:28638276
|
Ozturk O et al. |
Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication. |
2017 |
Arab J Gastroenterol |
pmid:28601610
|
Alirezaei A et al. |
Helicobacter pylori Eradication With Levofloxacin or Clarithromycin in Dialysis Versus Nonuremic Patients. |
2017 |
Iran J Kidney Dis |
pmid:28575885
|
Varma MV et al. |
Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of Montelukast. |
2017 |
Clin. Pharmacol. Ther. |
pmid:27648490
|
Huet D et al. |
[Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment]. |
2017 |
Rev Mal Respir |
pmid:27639948
|
Jia L et al. |
Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides. |
2017 |
Bioorg. Med. Chem. Lett. |
pmid:28711353
|
Zerbetto De Palma G et al. |
Occurrence of Mutations in the Antimicrobial Target Genes Related to Levofloxacin, Clarithromycin, and Amoxicillin Resistance in Helicobacter pylori Isolates from Buenos Aires City. |
2017 |
Microb. Drug Resist. |
pmid:27391421
|
Chen MJ et al. |
Impact of amoxicillin resistance on the efficacy of amoxicillin-containing regimens for Helicobacter pylori eradication: analysis of five randomized trials. |
2017 |
J. Antimicrob. Chemother. |
pmid:28961996
|
Lin CM et al. |
Is ionizing radiation a risk factor to diffuse panbronchiolitis? |
2017 |
QJM |
pmid:28069906
|
Makihara K et al. |
Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients. |
2017 |
Cancer Chemother. Pharmacol. |
pmid:28711984
|
Tanabe H et al. |
Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature. |
2017 |
Dig. Dis. Sci. |
pmid:28664410
|
Fohner AE et al. |
PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics. |
2017 |
Pharmacogenet. Genomics |
pmid:28146011
|
Branquinho D et al. |
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics? |
2017 |
BMC Gastroenterol |
pmid:28202013
|
Inukai K et al. |
Effect of gel formation on the dissolution behavior of clarithromycin tablets. |
2017 |
Int J Pharm |
pmid:28196716
|
Miftahussurur M et al. |
Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Infection in the Dominican Republic. |
2017 |
Am. J. Trop. Med. Hyg. |
pmid:28193745
|
Liou JM et al. |
Toward population specific and personalized treatment of Helicobacter pylori infection. |
2018 |
J. Biomed. Sci. |
pmid:30285834
|
Liu HY et al. |
Bilateral Non-tuberculous Mycobacterial Keratitis After Small Incision Lenticule Extraction. |
2018 |
J Refract Surg |
pmid:30199569
|
Long X et al. |
Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance. |
2018 |
Helicobacter |
pmid:29696736
|
Hosono Y et al. |
The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study. |
2018 |
J. Infect. Chemother. |
pmid:29361415
|